Opportunity Information: Apply for PA 09 133
Apply for PA 09 133
- The National Institutes of Health in the food and nutrition health sector is offering a public funding opportunity titled "Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
- This funding opportunity was created on Mar 17, 2009 and posted on Mar 17, 2009.
- Applicants must submit their applications by May 7, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- Eligible applicants include: Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal governments (Federally recognized) Special district governments For profit organizations other than small businesses Small businesses Others (see text field entitled Additional Information on Eligibility for clarification) Independent school districts City or township governments State governments County governments.
- Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Non domestic (non U.S.) Entities (Foreign Organizations) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21) opportunity (Funding Opportunity Number PA 09 133) is a National Institutes of Health discretionary grant program led by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) in partnership with the NIH Office of Dietary Supplements (ODS). Its main goal is to support early stage, exploratory clinical research that could meaningfully improve how diabetes, obesity, endocrine disorders, and genetic metabolic diseases are prevented or treated. The focus is on short term clinical studies that let investigators test fresh ideas quickly, without the heavy expectation of extensive preliminary data that is typical for larger clinical trials and later stage awards. In practical terms, this funding is meant to help researchers find out whether a new clinical concept is workable and promising enough to justify bigger, more definitive studies later on.
A central theme of the program is “pilot and feasibility†work: small, carefully designed clinical projects that answer high impact questions and reduce uncertainty. The announcement specifically highlights studies that test new prevention strategies, new interventions, or novel combinations of therapies. Another major priority is translation, meaning the program is particularly interested in helping move strong laboratory or preclinical discoveries into real world clinical testing. The scope explicitly spans diabetes and endocrine diseases as well as genetic metabolic diseases, and it also notes cystic fibrosis within that broader set of conditions, reflecting the program’s interest in metabolic and endocrine complications across disease areas.
The mechanism used is the NIH Exploratory/Developmental grant mechanism (R21). R21 awards are generally structured to fund early, concept testing work rather than large scale validation, which fits the stated goal of enabling short, targeted clinical studies. The notice lists an award ceiling of $200,000, signaling that projects should be scoped accordingly, with realistic milestones that can be achieved within an exploratory budget. At the same time, the announcement makes clear that the exact size, duration, total dollars awarded, and number of awards are not fixed in advance. Instead, those outcomes depend on the volume of applications received and, most importantly, the quality, cost, and proposed duration of the applications that are submitted and deemed meritorious.
Eligibility is broad and includes many types of domestic and non domestic organizations. Eligible applicants include public and state controlled institutions of higher education, private institutions of higher education, nonprofit organizations (including those with and without 501(c)(3) status), for profit organizations (including small businesses and other than small businesses), and a wide range of governmental entities such as state, county, city or township governments, special district governments, and independent school districts. The program also welcomes applications from Native American tribal governments (both federally recognized and other than federally recognized) and tribal organizations, tribally controlled colleges and universities, Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, Historically Black Colleges and Universities (HBCUs), faith based or community based organizations, regional organizations, U.S. territories or possessions, and even foreign organizations (non U.S. entities). The listing also notes that eligible agencies of the federal government may apply. There is no cost sharing or matching requirement, which lowers the barrier to participation for organizations that may not have discretionary funds to contribute.
In terms of administrative details, the opportunity falls under the “Food and Nutrition†and “Health†activity categories and is associated with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research). The announcement was posted and created on March 17, 2009, with an original closing date of May 7, 2012 and the same current closing date listed, after which it was archived on June 7, 2012. While it is an archived opportunity and not an active application window today, the summary still reflects the program’s intent: to provide a relatively fast, flexible funding path for early clinical testing that could open the door to larger clinical trials and, ultimately, changes in clinical practice for diabetes, obesity, and endocrine and metabolic diseases.
For applicants or readers who need the full text, the announcement points to the NIH Grants Guide link (http://grants.nih.gov/grants/guide/pa-files/PA-09-133.html). For technical access issues, it directs inquiries to the NIH Office of Extramural Research (OER) webmaster via FBOWebmaster@OD.NIH.GOV.
Frequently Asked Questions (FAQs)
What is the Pilot and Feasibility Clinical Research Grants in Diabetes, Endocrine and Metabolic Diseases (R21) opportunity?
It is an NIH discretionary grant opportunity (Funding Opportunity Number PA 09 133) designed to support early-stage, exploratory clinical research related to diabetes, obesity, endocrine disorders, and genetic metabolic diseases. The program emphasizes pilot and feasibility clinical studies that can quickly test new ideas and determine whether they are promising enough for larger, definitive studies later.
Which NIH institute leads this funding opportunity?
The program is led by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), in partnership with the NIH Office of Dietary Supplements (ODS).
What is the primary goal of this program?
The main goal is to support short-term, exploratory clinical research that could meaningfully improve how diabetes, obesity, endocrine disorders, and genetic metabolic diseases are prevented or treated. The intent is to reduce uncertainty and establish whether a clinical concept is workable and worth pursuing in larger studies.
What does "pilot and feasibility" mean in this context?
In this program, "pilot and feasibility" refers to small, carefully designed clinical projects that answer high-impact questions and test whether an approach is practical and promising. These studies are intended to be focused and exploratory rather than large-scale confirmatory trials.
What kinds of studies are highlighted as priorities?
The announcement specifically highlights short-term clinical studies that test new prevention strategies, new interventions, or novel combinations of therapies. It also emphasizes translation, meaning moving strong laboratory or preclinical discoveries into real-world clinical testing.
Is this program intended for large clinical trials?
No. The R21 mechanism is aimed at early, concept-testing work rather than large-scale validation. The opportunity is framed around short, targeted clinical studies rather than extensive, later-stage clinical trials.
What NIH grant mechanism is used for this opportunity?
The opportunity uses the NIH Exploratory/Developmental grant mechanism (R21).
How much funding is available per award?
The notice lists an award ceiling of $200,000, signaling that proposed projects should be scoped to fit an exploratory budget with realistic milestones.
Are the award amount, project duration, or number of awards fixed in advance?
No. The announcement states that the exact size, duration, total dollars awarded, and number of awards are not predetermined. These depend on factors such as the number of applications received and the quality, cost, and proposed duration of the meritorious applications.
What disease areas are within scope?
The scope spans diabetes and endocrine diseases as well as genetic metabolic diseases. The announcement also notes cystic fibrosis within this broader set of conditions, reflecting interest in metabolic and endocrine complications across disease areas.
Is translational research encouraged?
Yes. A major priority is translation, with particular interest in moving laboratory or preclinical discoveries into clinical testing.
What types of organizations are eligible to apply?
Eligibility is broad and includes many types of domestic and non-domestic organizations. Examples listed include public and state-controlled institutions of higher education, private institutions of higher education, nonprofit organizations (with or without 501(c)(3) status), for-profit organizations (including small businesses and other than small businesses), and a wide range of governmental entities.
Are state and local government entities eligible?
Yes. The opportunity lists state governments, county governments, city or township governments, special district governments, and independent school districts among eligible applicants.
Are tribal governments and tribal organizations eligible?
Yes. The listing includes Native American tribal governments (both federally recognized and other than federally recognized) and tribal organizations, as well as tribally controlled colleges and universities.
Are minority-serving institutions specifically included?
Yes. The eligibility list explicitly mentions Alaska Native and Native Hawaiian Serving Institutions, Hispanic Serving Institutions, and Historically Black Colleges and Universities (HBCUs).
Can faith-based or community-based organizations apply?
Yes. Faith-based or community-based organizations are explicitly included in the eligibility list.
Are U.S. territories or possessions included as eligible applicants?
Yes. The eligibility list includes U.S. territories or possessions.
Are foreign (non-U.S.) organizations eligible to apply?
Yes. The announcement indicates that foreign organizations (non-U.S. entities) are eligible applicants.
Can U.S. federal government agencies apply?
Yes. The listing notes that eligible agencies of the federal government may apply.
Is cost sharing or a matching contribution required?
No. The opportunity states there is no cost sharing or matching requirement.
What activity categories is this opportunity associated with?
The opportunity falls under the "Food and Nutrition" and "Health" activity categories.
What CFDA number is associated with this program?
The opportunity is associated with CFDA number 93.847 (Diabetes, Digestive, and Kidney Diseases Extramural Research).
When was this funding opportunity posted, and what were the closing dates?
The announcement was posted/created on March 17, 2009. The original closing date was May 7, 2012, and the same date is listed as the current closing date in the summary. The opportunity was archived on June 7, 2012.
Is this opportunity still open for applications?
Based on the provided information, it is an archived opportunity and is not an active application window today. The listed closing date is May 7, 2012, and it was archived on June 7, 2012.
Where can applicants find the full funding announcement text?
The announcement points to the NIH Grants Guide: http://grants.nih.gov/grants/guide/pa-files/PA-09-133.html
Who should be contacted for technical access issues related to the announcement?
For technical access issues, inquiries are directed to the NIH Office of Extramural Research (OER) webmaster at FBOWebmaster@OD.NIH.GOV.
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Food and Nutrition Health
Next opportunity: Technological Innovation and Cooperation for Foreign Information Access Program CFDA 84.337A
Previous opportunity: Research on Clinical Decision Making in People with or at Risk for Life Threatening Illness (R21)
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 09 133
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (PA 09 133) also looked into and applied for these:
| Funding Opportunity |
|---|
| Silvio O. Conte Digestive Diseases Research Core Centers (P30) Apply for RFA DK 09 005 Funding Number: RFA DK 09 005 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Renal Function and Chronic Kidney Disease in Aging (R01) Apply for PA 09 165 Funding Number: PA 09 165 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Nutrition Obesity Research Centers (P30) Apply for RFA DK 09 006 Funding Number: RFA DK 09 006 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Non Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological and Digestive Diseases and Hypertensive Disorders (R01) Apply for PA 09 181 Funding Number: PA 09 181 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Ancillary Studies of Acute Kidney Injury, Chronic Kidney Disease, and End Stage Renal Disease Accessing Information from Clinical Trials, Epidemiological Studies, and Databases (R01) Apply for PA 09 196 Funding Number: PA 09 196 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Advances in Polycystic Kidney Disease (R01) Apply for PA 09 202 Funding Number: PA 09 202 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| NIDDK Small Grants for Clinical Scientists to Promote Diversity in Health Related Research (R03) Apply for PAR 09 223 Funding Number: PAR 09 223 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $125,000 |
| Public Private Alliances Related to Nutrition in Peru Apply for M OAA GRO EGAS 09 232 HPERU Funding Number: M OAA GRO EGAS 09 232 HPERU Agency: Agency for International Development Category: Food and Nutrition Health Funding Amount: $1,500,000 |
| Calcium Oxalate Stone Diseases (R01) Apply for PA 09 213 Funding Number: PA 09 213 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Consortium of Food Allergy Research (CoFAR) and CoFAR Statistical and Clinical Coordinating Center (CoFAR SACCC) (U19 and U01) Apply for RFA AI 09 039 Funding Number: RFA AI 09 039 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Small Grant Program for NIDDK K01/K08/K23 Recipients (R03) Apply for PAR 09 230 Funding Number: PAR 09 230 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $50,000 |
| Cystic Fibrosis Research and Translation Core Centers (P30) Apply for RFA DK 09 009 Funding Number: RFA DK 09 009 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $750,000 |
| Ancillary Studies to Major Ongoing Clinical Research Studies to Advance Areas of Scientific Interest within the Mission of the NIDDK (R01) Apply for PAR 09 247 Funding Number: PAR 09 247 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Pilot Studies for Studying the Mechanisms of Improvement in Type 2 Diabetes and Cardiovascular Risk Factors or in Cardiovascular, Lung, or Sleep Diseases after Bariatric Surgery (R01) Apply for RFA DK 09 012 Funding Number: RFA DK 09 012 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $400,000 |
| Beta Cell Biology Consortium (U01) Apply for RFA DK 09 011 Funding Number: RFA DK 09 011 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition for Continuation of the Randomized Intervention for Vesicoureteral Reflux (RIVUR) (U01) Apply for RFA DK 09 502 Funding Number: RFA DK 09 502 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition Clinical Centers and Data Coordinating Center for the Complementary and Alternative Medicine for Urological Symptoms (CAMUS) Trial (U01) Apply for RFA DK 09 503 Funding Number: RFA DK 09 503 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Limited Competition Coordinating Center For The Beta Cell Biology Consortium (U01) Apply for RFA DK 09 504 Funding Number: RFA DK 09 504 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Stimulating Hematology Investigation New Endeavors (SHINE) (R01) Apply for PAS 10 046 Funding Number: PAS 10 046 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: Case Dependent |
| Human Brown Adipose Tissue Methods for Measurement of Mass and Activity (R21) Apply for RFA DK 10 002 Funding Number: RFA DK 10 002 Agency: National Institutes of Health Category: Food and Nutrition Health Funding Amount: $200,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 09 133", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
